A core challenge in biology is understanding how processes in the body, such as cellular development and regeneration, unfold ...
Morning Overview on MSN
Hundreds of autism genes just turned out to hit the brain the same way — all funneling into one shared pathway that could become a single drug target
For more than two decades, the genetics of autism seemed to splinter in every direction. Each new sequencing study added ...
A new review highlights how synthetic biology, AI, and spatial omics could transform ligand-receptor discovery from one-by-one searches into network-level mapping.
A new review highlights how synthetic biology, AI, and spatial omics could transform ligand-receptor discovery from one-by-one searches into ...
Morning Overview on MSN
Researchers just mapped the brain’s entire histamine system for the first time — wiring that shapes sharp thinking and drives vulnerability to mental illness
When you take an allergy pill and feel foggy for the rest of the afternoon, you are experiencing a crude demonstration of ...
Exploring the differentiation of iPSC to trunk tenocytes and how the single-cell RNA sequencing and pathway analysis can assist in making it more specific.
A novel spatial transcriptomics atlas developed by Northwestern Medicine scientists may improve the understanding of niche cellular interactions in the gastrointestinal tract that promote the ...
The immune system exhibits remarkable plasticity, enabling dynamic responses to environmental cues while maintaining tissue homeostasis. Emerging evidence ...
Sanyou Biopharmaceuticals announced today that its independently developed AI-STAL has undergone a significant upgrade, successfully achieving a qualitative leap from "molecular treasure trove" to ...
Introduction Respiratory syncytial virus (RSV) is the leading cause of severe lower respiratory tract infection in infants globally. Newborns, especially those born prematurely, are at increased risk ...
Multiple milestones achieved or on track across wholly owned and partnered programs REC-1245 (RBM39 degrader): Early clinical data in solid ...
Multiple milestones achieved or on track across wholly owned and partnered programs REC-1245 (RBM39 degrader): Early clinical data in solid tumors demonstrate a well-tolerated safety profile and predi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results